Also, we showed that siRNA-induced silencing of either LDH-A or LDH-B genes in ER- or ER + breast cancer cells, or the use of pharmacological LDH inhibitors to reduce LDH activity, resulted in reduced extracellular lactate and cell motility. The gene discussed is LDHB; the disease is breast cancer.